Erratum: MiR-24 limits aortic vascular inflammation and murine abdominal aneurysm development (Nature Communications (2014) 5:5214 DOI: 10.1038/ncomms6214);MiR-24 limits aortic vascular inflammation and murine abdominal aneurysm development

Nature Communications

Volumn 5, Issue , 2014, Pages

  Maegdefessel, Lars ^a,b   Spin, Joshua M ^a,c   Raaz, Uwe ^a   Eken, Suzanne M ^b   Toh, Ryuji ^a   Azuma, Junya ^d   Adam, Matti ^a   Nagakami, Futoshi ^a   Heymann, Helen M ^a   Chernugobova, Ekaterina ^b   Jin, Hong ^b   Roy, Joy ^b   Hultgren, Rebecka ^b   Caidahl, Kenneth ^b   Schrepfer, Sonja ^e   Hamsten, Anders ^b   Eriksson, Per ^b   McConnell, Michael V ^a   Dalman, Ronald L ^f   Tsao, Philip S ^a,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^d OSAKA UNIVERSITY   (Japan)

^e UNIVERSITY HEART CENTER HAMBURG   (Germany)

^f STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHITINASE; CHITINASE 3 LIKE 1; INTERLEUKIN 6; INTERLEUKIN 8; MICRORNA 24; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CHI3L1 PROTEIN, MOUSE; CHITINASE 3 LIKE PROTEIN 1; GLYCOPROTEIN; MICRORNA; MIRN24 MICRORNA, MOUSE;

CARDIOVASCULAR DISEASE; CYTOLOGY; GENE EXPRESSION; PLASMA;

ABDOMINAL AORTA ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DOWN REGULATION; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; VASCULITIS; ANIMAL; AORTA; AORTIC ANEURYSM, ABDOMINAL; BLOOD; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; ENDOTHELIUM CELL; HUMAN; INFLAMMATION; MALE; METABOLISM; SMOOTH MUSCLE CELL;

ANIMALIA; MURINAE;

ANIMALS; AORTA; AORTIC ANEURYSM, ABDOMINAL; BIOMARKERS; CELLS, CULTURED; CHITINASE-3-LIKE PROTEIN 1; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENDOTHELIAL CELLS; GLYCOPROTEINS; HUMANS; INFLAMMATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MYOCYTES, SMOOTH MUSCLE;

EID: 84923380956     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7506     Document Type: Erratum

References (58)

1. Lu, H., Rateri, D. L., Bruemmer, D., Cassis, L. A. & Daugherty, A. Novel mechanisms of abdominal aortic aneurysms. Curr. Atheroscler. Rep. 14, 402-412 (2012).
2. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233 (2009).
3. van Rooij, E. & Olson, E. N. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nature reviews. Drug Discov. 11, 860-872 (2012).
4. Shimizu, K., Mitchell, R. N. & Libby, P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 26, 987-994 (2006).
5. Juvonen, J. et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 17, 2843-2847 (1997).
6. Middleton, R. K. et al. The pro-inflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall: a protein array study. J. Vasc. Surg. 45, 574-580 (2007).
7. Satoh, H. et al. Expression and localization of tumour necrosis factor-alpha and its converting enzyme in human abdominal aortic aneurysm. Clin. Sci. 106, 301-306 (2004).
8. Maegdefessel, L. et al. MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion. Sci. Transl. Med. 4, 122ra122 (2012).
9. Maegdefessel, L. et al. Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J. Clin. Invest. 122, 497-506 (2012).
10. Boon, R. A. et al. MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ. Res. 109, 1115-1119 (2011).
11. Alexiou, P. et al. The DIANA-mirExTra web server: from gene expression data to microRNA function. PLoS ONE 5, e9171 (2010).
12. Bang, C., Fiedler, J. & Thum, T. Cardiovascular importance of the microRNA-23/27/24 family. Microcirculation 19, 208-214 (2012).
13. Sun, F. et al. Characterization of function and regulation of miR-24-1 and miR-31. Biochem. Biophys. Res. Commun. 380, 660-665 (2009).
14. Lee, C. G. et al. Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu. Rev. Physiol. 73, 479-501 (2011).
15. Fiedler, J. et al. MicroRNA-24 regulates vascularity after myocardial infarction. Circulation 124, 720-730 (2011).
16. Zhou, Q. et al. Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23B27B24 clusters. Proc. Natl Acad. Sci. USA 108, 8287-8292 (2011).
17. Lu, H., Cassis, L.A. & Daugherty, A. Atherosclerosis and arterial blood pressure in mice. Curr. Drug Targets 8, 1181-1189 (2007).
18. Tang, H. et al. YKL-40 induces IL-8 expression from bronchial epithelium via MAPK (JNK and ERK) and NF-kappaB pathways, causing bronchial smooth muscle proliferation and migration. J. Immunol. 190, 438-446 (2013).
19. Wang, J. et al. MicroRNA-24 regulates cardiac fibrosis after myocardial infarction. J. Cell. Mol. Med. 16, 2150-2160 (2012).
20. Lapierre, M. et al. Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells' malignant phenotypes: role of tissue inhibitors of metalloproteinase-1. Cancer Res. 67, 9030-9034 (2007).
21. Stawowy, P. et al. Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-pro-matrix metalloproteinase-2 proteolytic cascade in atherosclerosis. Circulation 111, 2820-2827 (2005).
22. Bail, S. et al. Differential regulation of microRNA stability. RNA 16, 1032-1039 (2010).
23. Gantier, M. P. et al. Analysis of microRNA turnover in mammalian cells following Dicer1 ablation. Nucleic Acids Res. 39, 5692-5703 (2011).
24. Spin, J. M. et al. Transcriptional profiling and network analysis of the murine angiotensin II-induced abdominal aortic aneurysm. Physiol. Genomics 43, 993-1003 (2011).
25. Thum, T. et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980-984 (2008).
26. van Rooij, E. et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl Acad. Sci. USA 105, 13027-13032 (2008).
27. Rayner, K. J. et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328, 1570-1573 (2010).
28. Bonauer, A. et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324, 1710-1713 (2009).
29. Qian, L. et al. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J. Exp. Med. 208, 549-560 (2011).
30. Melkman-Zehavi, T. et al. miRNAs control insulin content in pancreatic betacells via downregulation of transcriptional repressors. EMBO J. 30, 835-845 (2011).
31. Wang, T. et al. A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. Genes Chromosomes Cancer 46, 336-347 (2007).
32. Li, X. et al. c-MYC-regulated miR-23a/24-2/27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2. J. Biol. Chem. 288, 18121-18133 (2013).
33. Martin, E. C. et al. Preferential star strand biogenesis of pre-miR-24-2 targets PKC-alpha and suppresses cell survival in MCF-7 breast cancer cells. Mol. Carcinog. 53, 38-48 (2012).
34. Srivastava, N. et al. miR-24-2 controls H2AFX expression regardless of gene copy number alteration and induces apoptosis by targeting antiapoptotic gene BCL-2: a potential for therapeutic intervention. Breast Cancer Res. 13, R39 (2011).
35. Volck, B. et al. YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc. Assoc. Am. Physicians 110, 351-360 (1998).
36. Vos, K. et al. Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions. Ann. Rheum. Dis. 59, 544-548 (2000).
37. Boot, R. G. et al. Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler. Thromb. Vasc. Biol. 19, 687-694 (1999).
38. Rehli, M. et al. Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation. J. Biol. Chem. 278, 44058-44067 (2003).
39. Nishikawa, K. C. & Millis, A. J. gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells. Exp. Cell. Res. 287, 79-87 (2003).
40. Hartl, D., Lee, C. G., Da Silva, C. A., Chupp, G. L. & Elias, J. A. Novel biomarkers in asthma: chemokines and chitinase-like proteins. Curr. Opin. Allergy Clin. Immunol. 9, 60-66 (2009).
41. Ridker, P. M., Chasman, D. I., Rose, L., Loscalzo, J. & Elias, J. A. Plasma levels of the proinflammatory chitin-binding glycoprotein YKL-40, variation in the chitinase 3-like 1 gene (CHI3L1), and incident cardiovascular events. J. Am. Heart Assoc. 3, e000897 (2014).
42. Ashburner, B. P., Westerheide, S. D. & Baldwin, Jr. A. S. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol. Cell. Biol. 21, 7065-7077 (2001).
43. Baetz, D. et al. Nuclear factor-kappaB-mediated cell survival involves transcriptional silencing of the mitochondrial death gene BNIP3 in ventricular myocytes. Circulation 112, 3777-3785 (2005).
44. Nozaki, S., Sledge, Jr G. W. & Nakshatri, H. Repression of GADD153/CHOP by NF-kappaB: a possible cellular defense against endoplasmic reticulum stressinduced cell death. Oncogene 20, 2178-2185 (2001).
45. Yoshimura, K. et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat. Med. 11, 1330-1338 (2005).
46. Ghosh, A. et al. The role of extracellular signal-related kinase during abdominal aortic aneurysm formation. J. Am. Coll. Surg. 215, 668-680 e661 (2012).
47. Mishra, P. K., Tyagi, N., Kumar, M. & Tyagi, S. C. MicroRNAs as a therapeutic target for cardiovascular diseases. J. Cell. Mol. Med. 13, 778-789 (2009).
48. Kastrup, J. Can YKL-40 be a new inflammatory biomarker in cardiovascular disease? Immunobiology 217, 483-491 (2012).
49. Engelhardt, S. Small RNA biomarkers come of age. J. Am. Coll. Cardiol. 60, 300-303 (2012).
50. Zampetaki, A. & Mayr, M. Analytical challenges and technical limitations in assessing circulating miRNAs. Thromb. Haemost. 108, 592-598 (2012).
51. Mendell, J. T. & Olson, E. N. MicroRNAs in stress signaling and human disease. Cell 148, 1172-1187 (2012).
52. Zampetaki, A. et al. Prospective study on circulating MicroRNAs and risk of myocardial infarction. J. Am. Coll. Cardiol. 60, 290-299 (2012).
53. Azuma, J., Asagami, T., Dalman, R. & Tsao, P. S. Creation of murine experimental abdominal aortic aneurysms with elastase. J. Vis. Exp. doi: 10.3791/1280 (2009).
54. Goergen, C. J. et al. Influences of aortic motion and curvature on vessel expansion in murine experimental aneurysms. Arterioscler. Thromb. Vasc. Biol. 31, 270-279 (2011).
55. Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA 98, 5116-5121 (2001).
56. Huang da, W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13 (2009).
57. Azuma, J. et al. Assessment of elastase-induced murine abdominal aortic aneurysms: comparison of ultrasound imaging with in situ video microscopy. J. Biomed. Biotechnol. 2011, 252141 (2011).
58. Ishida, N. et al. CCR1 acts downstream of NFAT2 in osteoclastogenesis and enhances cell migration. J. Bone Miner. Res. 21, 48-57 (2006).